Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
67 results about "PCI - Percutaneous coronary intervention" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Percutaneous coronary intervention (PCI) is a non-surgical procedure used to treat narrowing (stenosis) of the coronary arteries of the heart found in coronary artery disease.
Methods of treatment of patients at increased risk of development of ischemic events and compounds hereof
InactiveUS20130040898A1Impair thrombus formationIncreased riskElcosanoid active ingredientsInorganic active ingredientsBeta blockerPlatelet inhibitors
The present invention relates to compounds for treatment that protects the endothelium, prevents pathologic thrombus formation in the microcirculation and preserves platelet number and function and thus may be related to treatment or prevention of ischemic events in patients with cardiovascular disease. The present invention is particularly useful for patients having or being at increased risk of development of an ischemic event such as an acute myocardial infarction and / or no-reflow phenomena and / or ischemia-reperfusion injury by administration of agent(s) modulating and / or preserving endothelial integrity. The compounds may be administered in combination with standard treatment of acute cardiovascular ischemic events such as Platelet inhibitors such as aspirin (ASA), Thienopyridins, GPIIb / IIIa inhibitors), Parenteral anticoagulants such as unfractioned heparin (UFH), bivalirudin, enoxaparin, and fondaparinux, Verapamil, Adenosine, Sodium nitroprusside, Nitroglycerin, Epinephrine, Beta-blockers and surgical methods such as percutaneous coronary intervention (PCI), PCI with thrombus aspiration, PCI with stents.
Owner:THROMBOLOGIC
Intravascular delivery system and method for percutaneous coronary intervention
PendingUS20190255299A1Efficient and minimally traumaticSuperior crossabilityStentsBalloon catheterInsertion stentDelivery system
The subject guide catheter extension / pre-dilatation system includes an outer delivery sheath, an inner member extending within the sheath, and a mechanism for engagement / disengagement of the inner member to / from the sheath. The inner member is configured with a tapered distal tip having a delivery micro-catheter and a pre-dilatation balloon member attached to the tapered distal tip. The guidewire and a guide catheter are advanced to the vicinity of the treatment site within a blood vessel. Subsequently, the inner member and outer delivery sheath, in their engaged configuration, are advanced along the guidewire inside the guide catheter towards the site of treatment. At the treatment site, the balloon member is inflated for pre-dilatation treatment. The inner member is disengaged and retracted from the outer delivery sheath, and a stent is delivered to the treatment site.
Owner:VANTIS VASCULAR INC
Methods of treating, reducing the incidence of, and/or preventing ischemic events
ActiveUS8680052B1Reduce morbidityPreventing an ischemic eventOrganic active ingredientsPeptide/protein ingredientsThrombusPharmaceutical medicine
Methods of treating, reducing the incidence of, and / or preventing an ischemic event in a patient undergoing percutaneous coronary intervention (PCI), comprising administering to the patient a pharmaceutical composition comprising cangrelor. The method may further comprise administering an additional therapeutic agent to the patient, the additional therapeutic agent comprising a P2Y12 inhibitor. Pharmaceutical compositions useful for treating, reducing the incidence of, and / or preventing an ischemic event in a patient undergoing PCI. The pharmaceutical compositions comprise cangrelor. Methods of preparing a pharmaceutical composition for treating, reducing the incidence of, and / or preventing an ischemic event in a patient undergoing PCI, comprising admixing cangrelor with one or more pharmaceutically acceptable excipients. An ischemic event may include stent thrombosis, myocardial infarction, ischemia-driven revascularization, and mortality.
Owner:CHIESI FARM SPA
Vascular stent which is specially designed for the multiple drug loading and better drug elution
InactiveUS20070123974A1Effectively elutes drugs for a long period of timeEasy to eluteStentsSurgeryCoronary arteriesMedicine
Provided is a vascular stent used in percutaneous coronary intervention (PCI) which is specially designed for multiple drug loading and improved drug elution, including: a plurality of ring structures extending in the longitudinal direction of the vascular stent, including a plurality of struts disposed in a zigzag formation and connected to each other to form a cylindrical loop; and a plurality of link structures disposed between the ring structures and connecting the ring structures in the longitudinal direction of the vascular stent, wherein each of the struts in a ring structure is connected to adjacent struts in the same ring structure through one of a plurality of linking ends, a slot loaded with drugs is formed in the strut in the longitudinal direction of the strut, and a multi-layer structure comprising a plurality of layers of drugs is loaded in the slot. The vascular stent effectively inhibits restenosis by loading a large amount of a drug or various types of drugs in multiple layers in slots of struts in the vascular stent and controlling elution of the drugs, and can be easily installed in a serpentine coronary artery with excellent flexibility. In addition, the link structure of the vascular stent is disposed in a symmetric formation, and thus, side branch accessibility is excellent and an additional coronary intervention can be performed easily in a branched artery.
Owner:SAMSUNG LIFE PUBLIC WELFARE FOUND
Medical use of salvianolic acid A
InactiveCN102210666ALow viscosityReduce volumeOrganic active ingredientsNervous disorderIonPhosphodiesterase activity
The invention relates to the technical field of medicines and discloses the new use of salvianolic acid A, in particular the use of salvianolic acid A in the preparation of medicines for increasing cyclic adenosine monophosphate (CAMP) content in soterocyte and / or blood plasma, preparation of medicines for inhibiting activity of phosphodiesterase in soterocyte, preparation of medicines for promoting activity of adenylate activating enzyme and preparation of medicines for inhibiting calcium ion concentration in cytoplasm of soterocyte, in particular preparation of medicines for preventing or treating myocardial ischemia-reperfusion injury caused by thrombolysis, percutaneous coronary intervention, coronary artery bypass surgery and the like.
Owner:无锡特吉特药物研究有限公司
Maintenance of platelet inhibition during antiplatelet therapy
A method of treating or preventing a disease or condition in a subject that was previously treated with at least one thienopyridine is described. The method includes administering to the subject an effective amount of at least one reversible, short-acting P2Yi2 inhibitor. The described method can be used for subjects diagnosed with symptoms such as stable or unstable angina, vascular ischemic events, atherosclerosis, acute coronary syndrome, as well as STEMi or N-STEMI. The described method can also be used for patients having previously received a stent, such as a bare metal stent or a drug-eluting stent, and the treatment or prevention of stent thrombosis. The method can be used prior to, during, or after an invasive procedure such as coronary artery bypass grafting, percutaneous coronary intervention, or other general surgical procedure.
Owner:CHIESI FARM SPA
Novel intrusive assisted circulation device
InactiveCN102475923ANo biocompatibility concernsEasy maintenanceSuction devicesHuman bodyAxial-flow pump
The invention belongs to the field of biomedical engineering and particularly relates to an intrusive assisted circulation device used in the department of cardiac surgery. The device is characterized in that a magnetic drive mode is adopted for power transmission. The device is divided into two parts, namely an invitro driving device and an auxiliary device capable of being implanting into a human body through percutaneous coronary intervention, wherein an invitro driving device main body is a rotating magnetic field generation device capable of generating a rotating magnetic field which is strong enough; the auxiliary device implanted into the human body is internally provided with a minitype axial flow pump; a high-energy magnet is embedded in an impeller of the minitype axial flow pump, and is driven to rotate by the rotating magnetic field so as to push blood to flow; and the pump is implanted into the part, crossing over an aortic valve or pulmonic valve, of a heart, so as to play a role in assisting the heart to pump blood, thus effectively relieving the cardiac muscle load and assisting heart recovery.
Owner:DALIAN CHUANGDA TECH TRADE MARKET
Reticulated endovascular stent
The invention discloses a reticulated endovascular stent which comprises a plurality of supporting unit rings and connecting bars, wherein the supporting unit rings consist of a plurality of wave-shaped bars with wave-shaped structures; the connecting bars are connected to the adjacent supporting unit rings to form the cylindrical reticulated endovascular stent, the axial length of each supporting unit ring is less than 1.36mm, and the optimal range is between 0.65mm and 1.03mm; the distance between every two adjacent supporting unit rings is less than 0.5mm, and the optimal range is between 0.1mm and 0.44mm; the connecting bars positioned among different supporting unit rings are axially crossly arranged; the connecting bars connected with the supporting unit rings at two axial ends of the stent are set to be n-shaped connecting bars, and other connecting bars are blocky entity bars and / or short curved bars; and wave crests and / or troughs of the curved bars are provided with strengthening rings strengthening the supporting force. The stent has smaller mesh, can effectively lower the postoperative restenosis rate, and improves the medical treatment effect. The reticulated endovascular stent is suitable to the interventional technique, and is especially suitable to the percutaneous coronary intervention.
Owner:MICROPORT NEUROTECH SHANGHAI
Von willebrand factor specific binders and methods of use therefor
InactiveUS20110158996A1Organic active ingredientsPeptide/protein ingredientsDosing regimenVon willebrand
The invention provides new uses for specific binders to the Al domain of the von Willebrand Factor (vWF), in particular the use in patients with stable angina undergoing elective percutaneous coronary intervention. Furthermore, dosing schedules and use of suitable assays such as RIPA and RICO in the particular disease settings are provided.
Owner:ABLYNX NV
Percutaneous coronary intervention radio frequency ablation electrode catheter
ActiveCN103300917AAvoid damageShorten the timeSurgical instruments for heatingRf ablationMaximum diameter
The invention relates to a percutaneous coronary intervention radio frequency ablation electrode catheter which comprises an outer pipe, a core pipe, a handle, a core pipe handle, electrodes, guide wires and electrode plugs, wherein the core pipe is arranged in the outer pipe; the handle is fixedly connected with the near end of the outer pipe; the core pipe handle is fixedly connected with the near end of the core pipe; the guide wires are connected with the electrodes; the electrode plugs are connected with a radio frequency ablatograph; the far end of the outer pipe is provided with an electrode bearing device; the far end of the outer pipe is fixedly connected with that of the core pipe; the electrode bearing device is provided with a plurality of strips; the strips are distributed in the circumferential direction of the outer pipe and are arranged in a staggered manner in the axial direction; the electrodes are fixed at the middle parts of the strips; and when the outer pipe and the core pipe oppositely move, the electrodes on the strips are hunched up in the radial direction and are distributed in a staggered manner. The radio frequency ablation electrode catheter greatly reduces damage to renal artery and moreover, the maximum diameter of the electrode bearing device at the far end of the radio frequency ablation electrode catheter can be correspondingly regulated according to the diameter of the blood vessel of a patient.
Owner:吕世文
Optical and ultrasonic image diagnosis and treatment effect integrated stent delivery system
InactiveCN107411858ARelieve painImprove accuracyStentsOrgan movement/changes detectionImage diagnosisInsertion stent
The invention relates to a stent delivery system integrating optical and ultrasonic image diagnosis and treatment functions. The stent delivery system is provided with a three-way connection, and the three-way connection is respectively connected with a connection end, a balloon tube and a protective tube. The connection end connects the device. The inside of the balloon tube is a protective tube, the proximal end of the balloon tube is connected to the propeller, the outside of the balloon is provided with a stent, the front end of the stent delivery system is provided with a probe, the protective tube at the front end of the probe is provided with a developing ring, and the front end of the protective tube is provided with a guide wire hole . The connector of the connection end is in the form of an integrated connector combining an electrical ferrule and an optical ferrule. The electrical ferrule and the optical ferrule are fixed inside the connector sheath. The probe integrates an acoustic probe and an optical probe, and both the acoustic probe and the optical probe are fixed on the shell. The system of the present invention has both diagnosis and treatment functions, can optimize and guide PCI treatment decision-making, and complete surgery at the same time, shorten operation time, improve operation success rate, and relieve patients' pain.
Owner:HORIMED TECH CO LTD
Coronary artery intervention-based end hole guide wire
InactiveCN105498070ASimple technologyShorten operation timeStentsGuide wiresCoronary arteriesMedical equipment
The invention discloses a coronary artery intervention-based end hole guide wire, and relates to medical equipment. In the percutaneous coronary intervention (PCI for short) and in the process of using a double guide wire track technology (BW for short), in order to make a second guide wire move forward smoothly without the assistance of a micro guide catheter, and avoid the winding operation of two guide wires and prevent a bracket from separating from a carrier, an end hole guide wire is utilized as the second guide wire. The end hole guide wire consists of a guide wire rod and a sleeve ring, wherein the sleeve ring is a circular ring; the cross section of the sleeve ring is a circular surface; the center line of the circular ring is parallel to the center line of the guide wire rod; and the sleeve ring is fixed to one side of the end part of the guide wire rod in a welding manner. According to the conventional operation of the PCI, a first guide wire is inserted into a blood vessel and penetrates through a narrow blood vessel infection focus to the far end of the blood vessel, and the position, at the guide catheter outside the body of a patient, of the sleeve ring of the end hole guide catheter is inserted by the first guide wire.
Owner:夏妍
Novel nitric oxide-eluting bioresorbable stents for percutaneous coronary interventions
Disclosed herein are bioresorbable stents which elute nitric oxide (NO). The stent is comprised of three main key design elements: a bioresorbable scaffold, a bioresorbable polymeric coating layer(s), and NO-releasing nanoparticles incorporated in the bioresorbable polymeric coating layer, and optionally also in the scaffold. The NO-releasing nanoparticles are made of nontoxic biocompatible and biodegradable materials; for example a chitosan polymer and optionally a sugar.
Owner:HEART BIOTECH
Application of brazilin in preparation of drugs
ActiveCN104173328APrevent proliferationInhibit migrationOrganic active ingredientsSenses disorderDiseaseProtein-Tyrosine Kinases
The invention discloses application of brazilin in preparation of products for prevention, mitigation and / or treatment of diseases related to protein tyrosine kinase activity abnormal increase and vascular proliferation. Brazilin has the effects of inhibiting protein tyrosine kinase (PTKs) activity and inhibiting proliferation and migration of the rat thoracic aortic vascular smooth muscle cell (VSMC). Brazilin can prevent, mitigate and / or treat PTKs activity abnormal increase related diseases like tumors, restenosis after percutaneous coronary intervention (PCI), atherosclerosis, high blood pressure, multiple sclerosis, diabetic retinopathy, endometriosis, psoriasis and other skin diseases, asthma and other diseases. Brazilin can prevent, mitigate and / or treat vascular proliferation related diseases like restenosis after PCI, atherosclerosis, high blood pressure, neointima formation after vascular transplantation, vascular diseases after organ transplantation, diabetic angiopathies and the like.
Owner:INST OF MATERIA MEDICA AN INST OF THE CHINESE ACAD OF MEDICAL SCI
Bedside Interface for Percutaneous Coronary Intervention Planning
A system configured to assess the severity of blockages in blood vessels, and in particular stenosis in blood vessels, is disclosed. It is further disclosed that measurements of the vessel are provided which allow assessment of the vessel (and in particular any stenosis or lesion of the vessel), simulating diagnostic visualization using the first and second visualization means. Displaying an image of a vessel on a first visualization device with a theranostic visualization based on pressure measurements obtained and on a second visualization device displaying an image of a vessel with a diagnostic visualization based on pressure measurements obtained is disclosed. A portion of the image, wherein the portion of the image of the vessel displayed on the second visualization device is a magnified view of the region of interest of the vessel.
Owner:KONINKLJIJKE PHILIPS NV +1
Guide catheter extension system with a delivery micro-catheter configured to facilitate percutaneous coronary intervention
ActiveUS11491313B2“crossability” of the distal tipSuperior crossabilityGuide needlesBalloon catheterCoronary arteriesGuide wires
Owner:VANTIS VASCULAR INC
Patient Education for Percutaneous Coronary Intervention
Owner:KONINKLJIJKE PHILIPS NV +1
Intravascular delivery system and method for percutaneous coronary intervention
ActiveUS20200179661A1Efficient and minimally traumaticEnhances the efficient and safe distal delivery of a guide extension deviceBalloon catheterGuide wiresCoronary arteriesIntrathecal use
The subject guide catheter extension / pre-dilatation system includes an outer delivery sheath, an inner member extending within the sheath, and a mechanism for engagement / disengagement of the inner member to / from the sheath. The inner member is configured with a tapered distal tip having a delivery micro-catheter and a pre-dilatation balloon member attached to the tapered distal tip in proximity to the micro-catheter. The outer delivery sheath and the inner member are modified for different engagement / disengagement mechanisms operation. The delivery micro-catheter provides for an improved crossability for the balloon member to the treatment site in an atraumatic, expedited and convenient fashion. During the cardiac procedure, a guidewire and a guide catheter are advanced to the vicinity of the treatment site within a blood vessel. Subsequent thereto, the inner member and outer delivery sheath, in their engaged configuration, are advanced along the guidewire inside the guide catheter towards the site of treatment. Once at the treatment site, the balloon member is inflated for pre-dilatation treatment. Subsequently, the inner member is disengaged and retracted from the outer delivery sheath, and a stent is delivered to the treatment site inside the outer delivery sheath.
Owner:VANTIS VASCULAR INC
Ticagrelor dispersible tablet and preparation method thereof
InactiveCN107913254AImpurities increaseEasy to operateOrganic active ingredientsPill deliveryCoronary arteriesTicagrelor
The invention relates to a ticagrelor dispersible tablet which is used for patients who suffer from acute coronary arteries syndromes, including patients taking drug therapy and patients taking PCI (percutaneous coronary intervention) therapy. The ticagrelor dispersible tablet is prepared from ticagrelor as a raw material and an auxiliary material. The dispersible tablet is quick in disintegration, quick in absorption and high in bioavailability, is convenient to take, has few intestinal residues, has few side effects and tastes sweet, the medication compliance of the patients is particularlyeasily improved, the taste of the preparation is improved, no sticking phenomenon can be caused in the granulation and tableting process, and industrial production is facilitated.
Owner:ZHENGZHOU TAIFENG PHARMA CO LTD
Method for operating a diagnostic apparatus with an x-ray system and a position determination system for catheters together with diagnostic apparatus for performance of the method
InactiveUS20080025474A1Eliminate interferenceInterference minimizationSurgical navigation systemsInstrumentsX-rayX ray image
The invention relates to a method for operating a diagnostic apparatus with an x-ray system for generating x-ray images, which has an x-ray device and an image system for the x-ray device, with a system for determining the position of objects, for example a measurement catheter, and a control facility for at least the x-ray system, whereby after an x-ray pulse a first read-out containing useful information is saved as an x-ray image, immediately afterwards a second read-out not containing useful information is saved as an interference image, and the x-ray image is corrected for the purpose of minimizing interference. Such diagnostic apparatuses are used in various medical procedures, for example in PCI (Percutaneous coronary intervention) and cardiac EP (electrophysiology) interventions.
Owner:SIEMENS AG
Application of astragaloside IV in inhibiting local inflammatory response and treating arterial restenosis
PendingCN111249295AInhibition releasePrevent proliferationOrganic active ingredientsAntipyreticBalloon injuryCoronary arteries
The invention provides an application of astragaloside IV (AS-IV) in inhibiting local inflammatory response and treating arterial restenosis, and relates to the technical field of novel applications of traditional Chinese medicines. According to the invention, a rat carotid artery balloon injury model is established to simulate vascular intimal injury after percutaneous coronary intervention (PCI)surgery, and the inhibitory effect of the AS-IV on proliferation of VSMCs and inflammation in vivo is clarified, so that a novel safe and effective solution is provided for prevention and treatment of restenosis after the PCI surgery.
Owner:AFFILIATED HOSPITAL OF JINING MEDICAL UNIV
Pipe withdrawing device
The invention discloses a pipe withdrawing device comprising a hollow-structure push pipe. The front end of the push pipe is closed, and the rear end of the push pipe is open. The outer wall of the front section of the push pipe is sleeved with a telescopic balloon. A through hole is formed between a telescopic balloon inner cavity and a push pipe inner cavity. According to the pipe withdrawing device provided by the invention, when needing to be withdrawn, a micro conduit is moved back first till the front end is withdrawn into a guide conduit, then the pipe withdrawing device provided by the invention is stretched into the guide conduit, the inserting depth is observed through a depth mark till the telescopic balloon of the pipe withdrawing device reaches the position in front of the end of the micro conduit, then gas inflation or transfusion is conducted at an opening in the rear end of the push pipe, gas or liquid enters the telescopic balloon inner cavity through the through hole, thus the telescopic balloon expands and extends till a PTCA guide wire is pressed to the inner wall of the guide conduit, at the moment, the micro conduit continues to be withdrawn and pulled out, then the PTCA guide wire is not moved, and smooth conducting of the percutaneous coronary intervention (PCI) therapeutic technique can be ensured effectively.
Owner:APT MEDICAL HUNAN INC
Devices, systems, and methods for coronary intervention assessment, planning, and treatment based on desired outcome
The present disclosure relates generally to the assessment and treatment of vessels, including for percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). For example, some embodiments of the present disclosure are suited for identifying the available intervention technique(s) suitable to achieve a desired outcome selected or input by a user. For example, in some implementations a method comprises receiving pressure measurements obtained by one or more intravascular pressure-sensing instruments positioned within a vessel of a patient; receiving an input from a userregarding a desired pressure value for the vessel of the patient; identifying an available treatment option based on the received pressure measurements and the desired pressure value; and outputting,to a display device, a screen display including a visual representation of the available treatment option. Related devices and systems are also described.
Owner:IMPERIAL INNOVATIONS LTD
Application of salvianolate in preparation of kidney protective agent drugs
InactiveCN103417526AOrganic active ingredientsUrinary disorderSpontaneously hypertensive ratRenal protection
The invention provides application of salvianolate in preparation of kidney protective agent drugs. A study on effects of injection-use salvianolate on acute myocardial perfusion in acute myocardial infarction direct PCI (percutaneous coronary intervention) and prognosis founds that: subjects using the injection-use salvianolate, compared with other group subjects, after use of a contrast agent, may not have severe kidney injuries, and the injection-use salvianolate has a kidney protective effect. The invention also provides the application of magnesium lithospermate B in preparation of the kidney protective agent drugs. Effects of the magnesium lithospermate B on kidney microcirculation and overall hemorheology are studied through use of spontaneously hypertensive rats. Experiments prove that the magnesium lithospermate B in physiological and pathological states both can dose-dependently improve kidney cortex microcirculation, and show that the kidney protective effect of the magnesium lithospermate B is realized through direct improvement of the kidney microcirculation, so that the salvianolate and the magnesium lithospermate B can be used for preparation of the drugs for the prevention and treatment of the kidney injures caused by the contrast agent. The application of the salvianolate in preparation of the kidney protective agent drugs has great clinical application value.
Owner:SHANGHAI GREEN VALLEY PHARMA +1
Percutaneous coronary intervention device for treating acute coronary syndrome
InactiveCN114652945AImprove accuracyImprove securityBalloon catheterMedical devicesCoronary arteriesCatheter
The invention discloses a percutaneous coronary intervention device for treating acute coronary syndrome, relates to the technical field of medical treatment, and aims at solving the problem that when an existing intervention device inflates the interior of a balloon, excessive gas in the balloon is likely to happen, and blood vessels are hurt. The percutaneous coronary intervention device comprises a device body, and a first catheter is installed at one end of the device body; a second catheter is installed at the end, away from the device body, of the first catheter, the outer wall of the second catheter is sleeved with a balloon, an inflation device is arranged on the inner wall of the balloon, and when the interior of the balloon needs to be inflated, a handle can be rotated, so that the balloon is inflated; an existing mode that an injector is pressed by a hand is changed into a mode that the control switch is rotated to control the gas entering content, the accuracy degree of the gas entering the balloon content is improved, and meanwhile distribution of operation time is optimized.
Owner:王达
Diagnosis device possessing x ray system and catheter positioning system, and its operation method
InactiveCN1837953AReduce or completely eliminate distractionsTelevision system detailsColor television detailsX-rayCatheter
Owner:SIEMENS AG
Circulatory assist pump
ActiveUS20210008263A1Reduce hemolysisReduce harmControl devicesBlood pumpsCoronary arteriesEngineering
A minimally invasive circulatory support platform that utilizes an aortic stent pump or pumps. The platform uses a low profile catheter-based techniques and provides temporary and chronic circulatory support depending on the needs of the patient. Also described is a catheter-based temporary assist pump to treat patients with acute decompensated heart failure and provide circulatory support to subjects undergoing high risk percutaneous coronary intervention (“PCI”). Further described is a wirelessly powered circulatory assist pump for providing chronic circulatory support for heart failure patients. The platform and system are relatively easy to place, have higher flow rates than existing systems, and provide improvements in the patient's renal function.
Owner:SECOND HEART ASSIST INC
Medicament for preventing in-stent restenosis after vascular intervention and preparation method thereof
InactiveCN101274026AReasonable preparationPrevent restenosisSulfur/selenium/tellurium inorganic active ingredientsCardiovascular disorderPercent Diameter StenosisCoronary heart disease
The invention provides a medicine for preventing postoperative restenosis of coronary artery after percutaneous coronary intervention (PCI) and a preparation method, which pertain to the pharmacy field and are characterized in that: the medicine is prepared from the raw materials by decocting with water according to the following weight ratio: 25 to 35 of Chinese rhubarb: 10 to 20 of mirabilite: 10 to 20 of liquorice: 10 to 20 of cinnamon: 10 to 20 of peach kernel: 20 to 30 of leech: 15 to 25 of honeysuckle. The medicine of the invention solves the problems that the postoperative restenosis of coronary artery appearing in percutaneous coronary intervention (PCI) influences the curative effects and the conventional western medicines cause damage to liver function and renal function, massive hemorrhage, etc. when being used for preventing postoperative restenosis of coronary artery.
Owner:宫丽鸿
Scoring model for predicting success rate of coronary artery chronic complete occlusion interventional therapy
PendingCN111599475AEasy to predictImprove applicabilityMedical simulationResourcesCoronary arteriesPre-operative evaluation
The invention relates to the technical field of coronary artery chronic complete occlusion lesion preoperative evaluation, and discloses a scoring model for predicting the success rate of a coronary artery chronic complete occlusion lesion interventional therapy. The method comprises the following scoring variables: blunt occlusion, 1 point; calcification: 1 point; bending, 1 point; the occlusionlength>=20mm, 1 point; far-end occlusion lesion, 1 point; side branch circulation, 1 point; target blood vessel CABG history, 1 point; occlusion in a stent, 1 point; open occlusion, 1 point, and operator variables, -4 points. The model can be used for evaluating and predicting the complexity of chronic complete occlusion and better predicting the risk of failure of the CTO percutaneous coronary intervention treatment technology, the operator technology and experience are brought into the scoring standard for the first time, scoring variables are increased, and the method has the advantages ofhigh good in applicability and high in prediction capacity.
Owner:JIANGXI PROVINCIAL PEOPLES HOSPITAL
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com